eFFECTOR Therapeutics Inc
Biotechnology
Healthcare
EFTRW
40.67M shares
NASDAQ US
traded
22 Nov 2021
open
1.35
52 week high
2.25
high
1.36
52 week low
0.60
low
1.31
growth
-2.19%
previous Close
1.37
P/E ratio
3
market cap
div yield
0
usd
Jun 2021
qoq
revenue
net incoming
-5.55M
eps
0.42
214.65 %
eps surprise
0.00 %
net profit margin
-554800000 %
operating incoming
-5.04M
net change in cash
-263.43K
cash on hand
10.88M
cost of revenue
2.19M
top top